Tag

Pharmacy Benefit Managers

All articles tagged with #pharmacy benefit managers

politics12 days ago•7 min saved

Kansas Senate advances bipartisan plan to curb pharmacy benefit managers

The Kansas Senate passed, 32-8, a bipartisan bill (SB360) to tighten state oversight of pharmacy benefit managers, mandating price and reimbursement transparency, ensuring pharmacies are reimbursed at or above NADAC, and creating dispensing fees to support local and rural pharmacies. The measure targets practices like spread pricing and limited PBM audits, aiming to curb PBM power and reduce costs for consumers. The bill advances to the Kansas House, with supporters arguing it protects independent pharmacies and patients, while opponents warn it could raise insurance costs and challenge federal changes already underway.

via Hays Post|

#kansas-senate #local-pharmacies #pharmacy-benefit-managers

policy1 month ago•3 min saved

House Questions Health-Insurance Chiefs Over Premium Surges and Denials

In back-to-back House hearings, major health-insurance CEOs faced bipartisan grilling over rising premiums, prior-authorization rules, and claim denials, with lawmakers scrutinizing the role of PBMs and drug costs while insurers defend pricing as reflecting broader cost pressures in the system and subsidies remaining a political flashpoint.

via NBC News|

#drug-pricing #health-insurance #healthcare-policy

politics1 month ago•6 min saved

Bipartisan Health Deal Hitches Ride to Spending Bill as Trump's Plan Stalls

Lawmakers clinched a bipartisan health care package to be attached to the next government funding bill, including a crackdown on pharmacy benefit managers, renewals of public health programs, and $4.6 billion for community health centers; however, the broader health care affordability agenda pushed by Donald Trump is unlikely to pass on Capitol Hill due to GOP divisions, Senate rules, and reluctance to pursue more health initiatives via budget reconciliation.

via Politico|

#capitol-hill #healthcare #pharmacy-benefit-managers

health9 months ago•6 min saved

Family Sues Pharmacy and Middleman Over Price Hike Causing Son’s Fatal Asthma Attack

The Schmidtknecht family is suing a pharmacy benefit manager and Walgreens after their son Cole died from an asthma attack, which was exacerbated by a sudden price hike and lack of proper medication access due to formulary changes. The case highlights issues with opaque drug pricing and the influence of pharmacy benefit managers in the US healthcare system.

via NBC News|

#asthma #drug-pricing #health

politics1 year ago•1 min saved

Bipartisan Effort Targets Health Insurer and PBM Breakups

In response to the murder of UnitedHealthcare CEO Brian Thompson, Congress has introduced bipartisan bills aimed at dismantling major insurance monopolies by requiring companies to divest their pharmacy benefit managers (PBMs) within three years. The Patients Before Monopolies Act, sponsored by Senators Elizabeth Warren and Josh Hawley, targets companies like UnitedHealth Group, CVS, and Cigna, which dominate the U.S. prescription market. The legislation reflects growing public frustration with the healthcare industry, though its passage remains uncertain.

via Futurism|

#congress #healthcare #legislation

business1 year ago•1 min saved

Lawmakers Target Drug Middlemen, Triggering Healthcare Stock Decline

Shares of companies owning pharmacy benefit managers, including UnitedHealth, CVS Health, and Cigna, fell after a bipartisan bill was introduced to force health insurers or drug middlemen to divest their pharmacy businesses. The bill, backed by Senators Elizabeth Warren and Josh Hawley, aims to address conflicts of interest and reduce drug costs by separating pharmacy operations from health insurers. The legislation has caused significant market reactions, though its future remains uncertain.

via New York Post |

#bipartisan-bill #business #drug-prices

business1 year ago•2 min saved

"How PBMs and Policies Are Impacting Prescription Costs and Pharmacy Survival"

Pharmacy benefit managers (PBMs), acting as middlemen in the healthcare system, are significantly driving up prescription drug costs for millions of Americans, employers, and the government by steering patients toward more expensive drugs, charging high markups, and extracting hidden fees, despite their role being to reduce drug costs.

via The New York Times|

#business #drug-pricing #healthcare

health1 year ago•1 min saved

"Rising Prescription Costs: The Role of PBMs and Vanishing Independent Pharmacies"

Pharmacy benefit managers (P.B.M.s) like CVS Caremark, Express Scripts, and Optum Rx often make consumers pay more for medications than necessary. These middlemen, chosen by employers or government insurance programs, play a crucial role in determining drug costs. To find out if you're being overcharged, it's important to understand which P.B.M. manages your prescriptions.

via The New York Times|

#consumer-advice #health #healthcare-costs

business2 years ago•1 min saved

Mainline Pharmacy to Close Multiple Pennsylvania Locations Due to Economic Pressures

Mainline Pharmacy is closing most of its locations due to the high cost of medications versus low reimbursement from Pharmacy Benefit Managers, resulting in a loss of over $350,000 from filling over 17,500 prescriptions this year. Rite Aid will take over prescriptions for affected patients, with only the Somerset and LTC locations remaining open for now.

via WJAC Johnstown|

#business #closures #mainline-pharmacy

healthcare2 years ago•3 min saved

"CVS' Drug Price Revamp: Limited Impact on Consumers"

CVS Pharmacy's new drug pricing system, CVS CostVantage, aims to simplify and increase transparency in the payment structure for prescription medications. However, it is unlikely to result in lower costs or greater clarity for consumers. The new model primarily affects the arrangements between CVS Pharmacy, pharmacy benefit managers (PBMs), and payors such as insurers and employers. While the initiative may reduce the cost of most drugs, the savings will be passed along to PBMs and payors, with no mention of cost savings for consumers. Critics question whether the move will actually decrease costs or if it is merely a response to pressure from Congress and competitors.

via CNN|

#consumers #cvs-pharmacy #drug-pricing

healthcare2 years ago•2 min saved

CVS Implements New Pricing Model for Prescription Drugs

CVS is changing its drug pricing formula to increase transparency and simplify costs. The company will now base drug costs on the amount it pays for a drug, limiting the markup and service fee to customers. This move aligns with the industry's decision to be more straightforward with drug prices. The change will have a consumer impact starting in the first half of 2024 for those using cash pharmacy discount cards at CVS Pharmacy, and in 2025, the model will be launched with pharmacy benefit managers. The new pricing model is expected to benefit both pharmacies and consumers by providing more predictable reimbursement rates and potentially reducing overpayment for generic drugs.

via ABC News|

#consumer-friendly #cvs #drug-pricing

healthcare2 years ago•2 min saved

CVS revolutionizes drug pricing and reimbursement process

CVS is changing its pharmacy reimbursement model, aiming to bring more transparency and simplicity to drug pricing. The new approach, called CVS CostVantage, will use a simpler formula that includes the cost of the drug, a set markup, and a fee to determine the drug's price and reimbursement with pharmacy benefit managers. While the move could change the cost of prescription drugs for some patients, it may not necessarily make all medicine cost less. CVS executives expect that more prescription costs will fall than rise for consumers, employers, and health insurers. The announcement comes amid ongoing efforts to address the high cost of medications and the lack of transparency in the pricing process.

via CNN|

#cvs #drug-pricing #healthcare

health2 years ago•2 min saved

L.A. County Files Lawsuit Against Pharmacy Benefit Firms Over Opioid Crisis

Los Angeles County has filed a lawsuit against pharmacy benefit managers (PBMs) Express Scripts Inc. and OptumRx Inc., accusing them of colluding with drug manufacturers to promote addictive opioids as a safe pain treatment option. The county alleges that PBMs played a role in fueling the opioid crisis by determining which drugs get covered by insurance companies and how much patients pay for them. The lawsuit describes the devastating impact of the opioid crisis on the county's emergency rooms, schools, and child welfare system. Similar suits have been filed by other counties, alleging that PBMs turned a blind eye to signs of addiction and drug abuse.

via Los Angeles Times|

#addiction #health #lawsuit

healthcare2 years ago•3 min saved

Blue Shield of California's Shakeup: Ditching CVS for Amazon and Mark Cuban's Drug Company Sends Shockwaves

Blue Shield of California is shaking up the pharmacy benefit management (PBM) industry by dropping most services from CVS Caremark and partnering with Mark Cuban's Cost Plus Drugs, Amazon Pharmacy, and other companies to purchase and deliver drugs. The move aims to lower prescription drug prices and could potentially save the insurer up to $500 million annually. This shift may encourage other insurers to follow suit or pressure PBMs to modify their practices. Blue Shield's new model will begin ramping up next year and fully launch in 2025.

via USA TODAY|

#amazon-pharmacy #blue-shield-of-california #healthcare

healthcare2 years ago•2 min saved

Blue Shield of California Diversifies Pharmacy Network with Amazon and Mark Cuban's Cost Plus Drugs

Blue Shield of California, a non-profit insurer, plans to reduce its reliance on CVS Health as its pharmacy benefit manager and instead work with companies such as Amazon and Mark Cuban's drug firm to negotiate drug prices. This move comes as pharmacy benefit managers face scrutiny for their role in rising healthcare costs. Blue Shield will collaborate with five different companies to provide convenient access to medications while lowering costs. The insurer expects to save up to $500 million in annual drug costs once its multi-year strategy is fully implemented. CVS shares fell over 6% in response to the news.

via Reuters|

#amazon #blue-shield-of-california #cvs-health